| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1537-2995.2002.00011.X |
| P698 | PubMed publication ID | 11896308 |
| P50 | author | Paul M Ness | Q107569672 |
| P2093 | author name string | Michael B Streiff | |
| P2860 | cites work | Isolation and study of an acquired inhibitor of human coagulation factor V. | Q34520485 |
| Factor V anticoagulants: clinical, biochemical, and immunological observations | Q35579514 | ||
| Characterization of an acquired inhibitor to coagulation factor V. Antibody binding to the second C-type domain of factor V inhibits the binding of factor V to phosphatidylserine and neutralizes procoagulant activity | Q35613332 | ||
| Observations on a Factor-V Inhibitor | Q39353019 | ||
| Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis | Q40732016 | ||
| A circulating anticoagulant against factor V. | Q41974101 | ||
| Development of anti-bovine thrombin antibodies following neurosurgical procedures | Q43569429 | ||
| Fibrin glue: the perfect operative sealant? | Q44025606 | ||
| Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin | Q45162760 | ||
| Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin | Q47301020 | ||
| A Specific Inhibitor of Human Clotting Factor V | Q47689912 | ||
| Factor V Inhibitor: Report of a Case, with Comments on a Possible Effect of Streptomycin | Q47961135 | ||
| A case of factor V inhibitor | Q49194129 | ||
| Coagulopathy due to an acquired factor V inhibitor and subsequently thrombosis | Q49245498 | ||
| Factor V inhibitor and bullous pemphigoid | Q55647052 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 18-26 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Transfusion | Q15758500 |
| P1476 | title | Acquired FV inhibitors: a needless iatrogenic complication of bovine thrombin exposure | |
| P478 | volume | 42 |
| Q50144854 | A Case of Intraoperative Anaphylaxis Caused by Bovine-Derived Thrombin. |
| Q90639857 | A Possible Allergic Reaction Case to Thrombin Injected into Pseudoaneurysm After Radiofrequency Ablation |
| Q45882497 | A case of an asymptomatic idiopathic inhibitor to coagulation factor V. |
| Q88250871 | A discrepancy between prothrombin time and Normotest (Hepaplastintest) results is useful for diagnosis of acquired factor V inhibitors |
| Q37532508 | Achieving hemostasis in the surgical field |
| Q32182224 | Acquired Inhibitors to Multiple Coagulation Factors (V, IX, and XII) Identified in a Unique Patient with Hepatocellular Carcinoma |
| Q36328387 | Acquired coagulation inhibitor-associated bleeding disorders: an update |
| Q92433692 | Acquired factor V deficiency following transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report |
| Q38565993 | Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure |
| Q46411395 | Acquired factor V inhibitor associated with life-threatening bleeding and a mixing test result that indicated coagulation factor deficiency |
| Q42844307 | Acquired factor V inhibitor associated with valproic acid use in a cirrhotic patient |
| Q38193071 | Acquired factor V inhibitor in a patient with mantle cell lymphoma presenting with hematuria followed by thrombosis: a case report |
| Q37807275 | Acquired factor V inhibitors: a systematic review |
| Q34316233 | Acquired factor v inhibitor developing after treatment with dabigatran etexilate methanesulfonate: a case report and review of the literature |
| Q35882787 | Acquired inhibitor of factor V: first report in China and literature review |
| Q36187384 | Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management |
| Q90544660 | Antibacterial Activity of Leukocyte- and Platelet-Rich Plasma: An In Vitro Study |
| Q37144943 | Bleeding associated with acquired factor V inhibitor in a patient on warfarin treated successfully with prednisolone. |
| Q37492672 | Building an immune-mediated coagulopathy consensus: early recognition and evaluation to enhance post-surgical patient safety |
| Q35533347 | Characterization of the biological effect of fish fibrin glue in experiments on rats: immunological and coagulation studies |
| Q37586947 | Clinical use of topical thrombin as a surgical hemostat |
| Q37265091 | Collagen fleece-bound fibrin sealant is not associated with an increased risk of thromboembolic events or major bleeding after its use for haemostasis in surgery: a prospective multicentre surveillance study |
| Q86589637 | Complete response of acquired FV inhibitor to rituximab |
| Q57126805 | Cytocompatibility and mechanical properties of surgical sealants for cardiovascular applications |
| Q37784350 | Development of Cephradine-Induced Acquired Factor V Inhibitors: A Case Report |
| Q38490543 | Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature |
| Q81240317 | Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin |
| Q37266500 | Exogenous bovine thrombin as a biomarker of exposure and outcome |
| Q30276550 | Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue |
| Q44957871 | Immunogenicity of biologically-derived therapeutics: assessment and interpretation of nonclinical safety studies |
| Q28193941 | Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery |
| Q51135382 | Phase 2, randomized, double-blind, placebo-controlled, multicenter clinical evaluation of recombinant human thrombin in multiple surgical indications. |
| Q83179520 | Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model |
| Q34374779 | Renal injury and the application of polysaccharide hemospheres: a laparoscopic experimental model |
| Q36512498 | Risk of bleeding in surgical patients treated with topical bovine thrombin sealants: a review of the literature |
| Q90321030 | Severe serous cavity bleeding caused by acquired factor V deficiency associated with lymphatic leakage in a hemodialysis patient: A case report |
| Q37979181 | Thrombin use in surgery: an evidence-based review of its clinical use. |
| Q35185225 | Treating coagulopathy in trauma patients |
Search more.